Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jeffrey Swigris

Concepts (370)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Idiopathic Pulmonary Fibrosis
67
2025
634
12.770
Why?
Lung Diseases, Interstitial
57
2024
610
10.400
Why?
Quality of Life
46
2024
2688
6.660
Why?
Pulmonary Fibrosis
25
2024
385
5.760
Why?
Dyspnea
27
2024
239
5.340
Why?
Cough
10
2024
116
3.820
Why?
Oxygen Inhalation Therapy
13
2021
143
3.700
Why?
Surveys and Questionnaires
37
2024
5415
3.060
Why?
Vital Capacity
32
2024
289
2.980
Why?
Connective Tissue Diseases
13
2019
82
2.420
Why?
Alveolitis, Extrinsic Allergic
6
2024
97
1.970
Why?
Arthritis, Rheumatoid
12
2024
1098
1.870
Why?
Lymphangioleiomyomatosis
6
2024
34
1.850
Why?
Pyridones
12
2023
158
1.790
Why?
Patient Reported Outcome Measures
7
2024
374
1.700
Why?
Anti-Inflammatory Agents, Non-Steroidal
11
2021
338
1.580
Why?
Indoles
6
2024
383
1.550
Why?
Patient Outcome Assessment
3
2021
126
1.480
Why?
Sarcoidosis
5
2021
156
1.440
Why?
Humans
161
2025
129625
1.370
Why?
Lung
21
2024
3938
1.320
Why?
Severity of Illness Index
19
2024
2739
1.320
Why?
Aged
67
2025
22061
1.300
Why?
Middle Aged
79
2025
31136
1.300
Why?
Pulmonary Medicine
3
2022
79
1.290
Why?
Fatigue
9
2024
318
1.270
Why?
Walking
7
2013
500
1.190
Why?
Respiratory Function Tests
18
2024
581
1.100
Why?
Oxygen
7
2023
915
1.100
Why?
Psychometrics
10
2022
696
1.060
Why?
Patients
3
2018
169
1.040
Why?
Male
88
2025
63670
1.010
Why?
Health Care Costs
3
2018
367
1.000
Why?
Hypertension, Pulmonary
6
2023
1894
1.000
Why?
Female
91
2025
68734
0.980
Why?
Research Design
5
2016
1045
0.980
Why?
Exercise Test
9
2024
613
0.970
Why?
Health Status Indicators
4
2014
166
0.950
Why?
Activities of Daily Living
6
2022
382
0.940
Why?
Patient-Centered Care
2
2021
508
0.920
Why?
Reproducibility of Results
18
2024
3080
0.890
Why?
Disease Progression
19
2024
2627
0.880
Why?
Exercise Tolerance
4
2020
273
0.850
Why?
Caregivers
4
2019
806
0.790
Why?
Mycophenolic Acid
4
2016
110
0.790
Why?
Tomography, X-Ray Computed
17
2025
2512
0.790
Why?
Forced Expiratory Volume
12
2023
506
0.760
Why?
Internet
2
2016
618
0.740
Why?
Organizational Objectives
1
2021
73
0.720
Why?
Patient Satisfaction
3
2021
633
0.720
Why?
Nursing Research
1
2021
47
0.710
Why?
Pulmonary Emphysema
2
2024
275
0.670
Why?
Lactic Acid
1
2022
298
0.670
Why?
Chronic Disease
5
2022
1720
0.650
Why?
Symptom Assessment
1
2020
125
0.650
Why?
Rhinitis, Allergic
1
2020
38
0.650
Why?
Undifferentiated Connective Tissue Diseases
1
2019
1
0.640
Why?
Fatty Acids
1
2022
427
0.610
Why?
Pulmonary Disease, Chronic Obstructive
4
2022
984
0.610
Why?
Particulate Matter
1
2020
247
0.570
Why?
Emphysema
1
2018
109
0.560
Why?
Needs Assessment
2
2019
357
0.550
Why?
Patient Education as Topic
3
2019
737
0.550
Why?
Autoimmune Diseases
4
2019
427
0.550
Why?
Aged, 80 and over
19
2021
7052
0.550
Why?
Longitudinal Studies
9
2020
2720
0.540
Why?
Lung Diseases
3
2015
741
0.530
Why?
Qualitative Research
4
2017
1219
0.530
Why?
Lung Transplantation
1
2019
289
0.510
Why?
Pulmonary Diffusing Capacity
7
2019
74
0.510
Why?
United States
25
2024
13871
0.510
Why?
Treatment Outcome
20
2023
10219
0.510
Why?
Heart Rate
2
2011
802
0.500
Why?
Air Pollutants
1
2020
314
0.500
Why?
Adult
39
2024
35599
0.500
Why?
Exercise
4
2022
1928
0.490
Why?
Information Seeking Behavior
1
2016
33
0.490
Why?
Idiopathic Interstitial Pneumonias
6
2017
49
0.490
Why?
Immunosuppressive Agents
4
2016
858
0.490
Why?
Ambulatory Care
2
2018
506
0.490
Why?
Gastroesophageal Reflux
2
2021
232
0.470
Why?
Narration
1
2016
57
0.470
Why?
Prognosis
15
2024
3774
0.470
Why?
Double-Blind Method
10
2024
1875
0.470
Why?
Mental Health
2
2020
688
0.460
Why?
Telemedicine
1
2023
792
0.450
Why?
Kaplan-Meier Estimate
8
2018
851
0.450
Why?
Retrospective Studies
26
2025
14522
0.440
Why?
Antibodies, Monoclonal
1
2021
1366
0.440
Why?
Autoimmunity
2
2019
863
0.440
Why?
Biomedical Research
2
2018
640
0.440
Why?
Autoantibodies
6
2023
1468
0.420
Why?
Lung Neoplasms
4
2024
2342
0.420
Why?
Antitussive Agents
1
2013
7
0.410
Why?
Social Media
1
2016
141
0.410
Why?
Thalidomide
1
2013
32
0.410
Why?
Social Support
2
2019
584
0.400
Why?
Bronchiolitis Obliterans
1
2013
68
0.400
Why?
Survival Rate
7
2019
1872
0.400
Why?
Physicians
2
2019
866
0.400
Why?
Motivation
1
2017
547
0.400
Why?
Bronchial Diseases
1
2012
37
0.380
Why?
Follow-Up Studies
9
2018
4894
0.380
Why?
Patient Participation
1
2015
414
0.370
Why?
Quality Indicators, Health Care
1
2014
298
0.360
Why?
Scleroderma, Systemic
4
2019
114
0.360
Why?
Health Knowledge, Attitudes, Practice
2
2018
1280
0.360
Why?
Oxygen Consumption
3
2022
672
0.360
Why?
Health Status
5
2019
756
0.350
Why?
Hospitalization
3
2017
2057
0.340
Why?
Multivariate Analysis
5
2017
1499
0.340
Why?
Peptides, Cyclic
1
2012
256
0.340
Why?
Protein Kinase Inhibitors
3
2021
887
0.340
Why?
Motor Activity
1
2014
676
0.330
Why?
Endothelins
1
2010
62
0.330
Why?
Cause of Death
6
2019
395
0.320
Why?
Diagnosis, Differential
7
2019
1432
0.310
Why?
Pulmonologists
2
2019
15
0.310
Why?
Proportional Hazards Models
4
2019
1198
0.310
Why?
Pulmonary Embolism
1
2011
212
0.300
Why?
Amino Acyl-tRNA Synthetases
3
2016
30
0.300
Why?
Asthma
2
2020
2225
0.300
Why?
TRPP Cation Channels
1
2009
79
0.300
Why?
Endothelin-1
1
2010
179
0.290
Why?
Polycystic Kidney Diseases
1
2009
69
0.290
Why?
Palliative Care
3
2019
702
0.290
Why?
Prospective Studies
9
2021
7135
0.290
Why?
Sleep Apnea, Obstructive
1
2012
275
0.280
Why?
Cohort Studies
7
2024
5426
0.280
Why?
Randomized Controlled Trials as Topic
5
2017
1365
0.270
Why?
Sirolimus
2
2023
270
0.270
Why?
Consensus
2
2024
618
0.270
Why?
Home Care Services
2
2020
225
0.270
Why?
Vascular Endothelial Growth Factor D
3
2023
13
0.270
Why?
Exercise Therapy
3
2024
412
0.260
Why?
Bronchoalveolar Lavage Fluid
2
2025
646
0.260
Why?
Sex Distribution
3
2012
360
0.260
Why?
Biopsy
7
2016
1088
0.260
Why?
Tumor Suppressor Proteins
1
2009
314
0.260
Why?
Mortality
4
2019
307
0.260
Why?
Prevalence
5
2018
2564
0.260
Why?
Cost of Illness
3
2018
277
0.250
Why?
Myositis
3
2019
51
0.250
Why?
Patient Advocacy
2
2024
73
0.250
Why?
Quality Improvement
1
2014
1101
0.240
Why?
Lupus Erythematosus, Systemic
1
2008
247
0.240
Why?
Thrombosis
1
2008
348
0.220
Why?
Minimal Clinically Important Difference
2
2021
13
0.220
Why?
Fibrosis
2
2024
526
0.220
Why?
Time Factors
7
2019
6555
0.210
Why?
Databases, Factual
3
2019
1269
0.210
Why?
Age Distribution
3
2019
373
0.210
Why?
Delphi Technique
1
2024
225
0.200
Why?
Evidence-Based Medicine
2
2020
712
0.200
Why?
Respiratory Therapy
2
2019
23
0.190
Why?
Sex Factors
6
2019
1970
0.190
Why?
Environmental Exposure
2
2020
463
0.190
Why?
Receptors, Lysophosphatidic Acid
1
2021
30
0.190
Why?
Patient Care Management
1
2021
56
0.180
Why?
Incidence
3
2018
2641
0.180
Why?
Registries
3
2019
1899
0.170
Why?
Focus Groups
3
2016
450
0.170
Why?
Survival Analysis
3
2017
1269
0.170
Why?
Analysis of Variance
3
2015
1293
0.170
Why?
Linear Models
3
2019
819
0.170
Why?
Risk Factors
8
2021
9786
0.170
Why?
Logistic Models
4
2019
1986
0.170
Why?
Pain Measurement
1
2022
508
0.170
Why?
Interleukin-13
1
2021
147
0.170
Why?
Antibodies, Antinuclear
4
2016
66
0.170
Why?
Walk Test
2
2017
70
0.160
Why?
Sensitivity and Specificity
3
2015
1843
0.160
Why?
Chi-Square Distribution
2
2011
515
0.150
Why?
Terminal Care
2
2019
215
0.150
Why?
Allied Health Personnel
1
2019
41
0.150
Why?
General Practitioners
1
2019
26
0.150
Why?
Insurance Claim Review
1
2018
64
0.150
Why?
Lipid Metabolism
1
2022
503
0.150
Why?
Immunoglobulin A
1
2019
202
0.150
Why?
Anxiety
3
2019
972
0.150
Why?
Oxidation-Reduction
1
2022
1028
0.140
Why?
Accelerometry
2
2019
93
0.140
Why?
Cellular Senescence
1
2019
181
0.140
Why?
Cross-Sectional Studies
4
2019
5075
0.140
Why?
Physician Assistants
1
2019
88
0.140
Why?
Weight-Bearing
1
2018
162
0.130
Why?
Attitude to Health
2
2014
433
0.130
Why?
Germany
1
2017
100
0.130
Why?
Allergens
1
2020
385
0.130
Why?
Nurse Practitioners
1
2019
131
0.130
Why?
Perception
1
2019
344
0.130
Why?
Medicare
2
2018
708
0.130
Why?
Sulfonamides
2
2010
497
0.130
Why?
Common Variable Immunodeficiency
1
2016
26
0.130
Why?
Antihypertensive Agents
2
2010
485
0.130
Why?
Nurses
1
2019
166
0.130
Why?
Tidal Volume
1
2016
84
0.130
Why?
Host-Pathogen Interactions
1
2019
356
0.130
Why?
Clinical Trials as Topic
3
2024
1005
0.130
Why?
Granuloma
1
2016
89
0.120
Why?
Cyclophosphamide
1
2016
234
0.120
Why?
Muscle Strength
2
2015
303
0.120
Why?
Health Policy
1
2018
353
0.120
Why?
Interviews as Topic
2
2016
704
0.120
Why?
Physical Conditioning, Human
1
2015
39
0.120
Why?
Rituximab
1
2016
164
0.120
Why?
Neuroendocrine Cells
1
2015
31
0.120
Why?
Recovery of Function
1
2018
642
0.110
Why?
Nitric Oxide
1
2020
895
0.110
Why?
Case-Control Studies
4
2019
3378
0.110
Why?
Geographic Information Systems
1
2014
42
0.110
Why?
Societies, Medical
5
2020
744
0.110
Why?
Enzyme Inhibitors
2
2016
827
0.110
Why?
Sarcoidosis, Pulmonary
1
2015
83
0.110
Why?
Controlled Clinical Trials as Topic
1
2013
27
0.110
Why?
Sildenafil Citrate
1
2013
59
0.110
Why?
Information Dissemination
1
2016
205
0.110
Why?
Antifibrinolytic Agents
1
2014
47
0.110
Why?
Carbon Monoxide
3
2019
68
0.110
Why?
Predictive Value of Tests
3
2024
1947
0.100
Why?
Sulfones
1
2013
108
0.100
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2013
38
0.100
Why?
Endpoint Determination
1
2013
76
0.100
Why?
Phenotype
2
2018
3075
0.100
Why?
Smoking
3
2019
1500
0.100
Why?
Practice Guidelines as Topic
1
2020
1501
0.100
Why?
Antibiotics, Antineoplastic
1
2013
123
0.100
Why?
Self Report
2
2019
799
0.100
Why?
Patient Dropouts
1
2013
64
0.100
Why?
Purines
1
2013
172
0.100
Why?
Adaptation, Psychological
1
2017
617
0.100
Why?
Occupational Exposure
1
2016
299
0.100
Why?
Pulmonary Gas Exchange
1
2012
121
0.100
Why?
Histocompatibility Antigens Class II
1
2013
363
0.100
Why?
Vasodilator Agents
1
2013
326
0.090
Why?
Health Care Surveys
1
2014
557
0.090
Why?
Minnesota
1
2012
149
0.090
Why?
Delivery of Health Care
1
2018
898
0.090
Why?
Dust
1
2012
94
0.090
Why?
Clinical Competence
1
2019
1017
0.090
Why?
United Kingdom
1
2012
257
0.090
Why?
Piperazines
1
2013
340
0.090
Why?
Young Adult
5
2017
12455
0.090
Why?
Fear
1
2014
354
0.090
Why?
Hydrogen-Ion Concentration
1
2012
541
0.090
Why?
Epidemiologic Methods
1
2010
74
0.090
Why?
Anti-Infective Agents
1
2013
247
0.080
Why?
Health Surveys
1
2012
493
0.080
Why?
Pilot Projects
2
2015
1592
0.080
Why?
Sickness Impact Profile
2
2009
55
0.080
Why?
Salivary Glands, Minor
1
2009
9
0.080
Why?
Sjogren's Syndrome
1
2009
49
0.080
Why?
International Cooperation
3
2015
175
0.080
Why?
Hyperplasia
2
2015
175
0.080
Why?
Oximetry
1
2009
87
0.080
Why?
Risk
1
2011
855
0.070
Why?
Scleroderma, Limited
1
2008
5
0.070
Why?
Europe
3
2015
363
0.070
Why?
Poisson Distribution
3
2016
73
0.070
Why?
Sleep Wake Disorders
1
2011
252
0.070
Why?
Cardiac Catheterization
1
2011
520
0.070
Why?
Radiography
2
2016
797
0.070
Why?
Wound Healing
1
2010
307
0.070
Why?
Depression
2
2019
1317
0.070
Why?
Comorbidity
2
2017
1547
0.070
Why?
Models, Statistical
1
2011
625
0.070
Why?
Pericardium
1
2007
54
0.070
Why?
Clinical Trials, Phase III as Topic
2
2016
93
0.060
Why?
Seasons
1
2008
494
0.060
Why?
Medical Records
1
2006
170
0.060
Why?
Regression Analysis
3
2016
997
0.060
Why?
Singapore
1
2024
20
0.060
Why?
California
1
2005
400
0.060
Why?
Echocardiography
1
2007
634
0.050
Why?
Bronchoscopy
1
2025
216
0.050
Why?
Acute Disease
1
2006
979
0.050
Why?
Dose-Response Relationship, Drug
2
2020
2011
0.050
Why?
Data Interpretation, Statistical
2
2018
337
0.050
Why?
National Institutes of Health (U.S.)
1
2024
122
0.050
Why?
ROC Curve
1
2025
503
0.050
Why?
Terminology as Topic
1
2005
203
0.050
Why?
Lymphoid Tissue
1
2002
67
0.050
Why?
Whole Genome Sequencing
1
2023
129
0.050
Why?
Rheumatologists
1
2022
15
0.050
Why?
Exome
1
2023
221
0.050
Why?
Age Factors
3
2019
3152
0.050
Why?
Telomere
1
2024
233
0.050
Why?
Lysophospholipids
1
2021
72
0.050
Why?
Patient Care
1
2022
108
0.040
Why?
Patient Selection
1
2005
661
0.040
Why?
Attitude
1
2022
253
0.040
Why?
Genomics
1
2025
718
0.040
Why?
Adolescent
3
2017
20412
0.040
Why?
Total Lung Capacity
1
2019
33
0.040
Why?
Disease Models, Animal
1
2010
4078
0.040
Why?
Occupations
1
2019
42
0.040
Why?
Pulmonary Surfactant-Associated Protein A
1
2019
35
0.040
Why?
Pulmonary Surfactant-Associated Protein C
1
2019
44
0.040
Why?
GTPase-Activating Proteins
1
2019
81
0.040
Why?
Exoribonucleases
1
2019
43
0.040
Why?
Blood Gas Analysis
1
2019
71
0.040
Why?
ATP-Binding Cassette Transporters
1
2019
133
0.040
Why?
Education
1
2018
101
0.040
Why?
Watchful Waiting
1
2018
67
0.040
Why?
Administration, Inhalation
1
2020
667
0.040
Why?
Telomere-Binding Proteins
1
2019
102
0.040
Why?
DNA Helicases
1
2019
148
0.040
Why?
Administrative Claims, Healthcare
1
2017
26
0.040
Why?
Physical Endurance
1
2019
262
0.030
Why?
Forecasting
1
2019
361
0.030
Why?
Mucin-5B
1
2019
215
0.030
Why?
Telomerase
1
2019
234
0.030
Why?
Hypersplenism
1
2016
7
0.030
Why?
Spirometry
1
2017
255
0.030
Why?
Algorithms
1
2024
1616
0.030
Why?
Leukopenia
1
2016
28
0.030
Why?
Mass Screening
1
2024
1190
0.030
Why?
Sequence Analysis, DNA
1
2019
778
0.030
Why?
Banking, Personal
1
2016
2
0.030
Why?
Social Participation
1
2016
15
0.030
Why?
Creatine Kinase
1
2016
73
0.030
Why?
Health Care Sector
1
2016
23
0.030
Why?
Rheumatoid Factor
1
2017
167
0.030
Why?
Death Certificates
1
2016
29
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2019
487
0.030
Why?
Health Services Needs and Demand
1
2017
263
0.030
Why?
Biomarkers
2
2019
3968
0.030
Why?
Arthritis
1
2016
90
0.030
Why?
Commerce
1
2016
67
0.030
Why?
International Classification of Diseases
1
2016
122
0.030
Why?
Multiple Pulmonary Nodules
1
2015
19
0.030
Why?
Metals
1
2016
123
0.030
Why?
Promoter Regions, Genetic
1
2019
1207
0.030
Why?
Anthropometry
1
2015
204
0.030
Why?
Pandemics
1
2023
1491
0.030
Why?
Physical Examination
1
2016
234
0.030
Why?
Disease-Free Survival
1
2016
646
0.030
Why?
Genetic Variation
1
2019
939
0.030
Why?
Alberta
1
2013
14
0.030
Why?
Bronchiolitis
1
2015
90
0.030
Why?
Teaching
1
2016
217
0.030
Why?
Mortality, Premature
1
2013
12
0.030
Why?
Odds Ratio
1
2016
1019
0.030
Why?
Counseling
1
2016
386
0.030
Why?
Adrenal Cortex Hormones
1
2016
524
0.030
Why?
RNA
1
2019
882
0.030
Why?
Drug Therapy, Combination
1
2016
1042
0.030
Why?
Genome-Wide Association Study
1
2019
1326
0.020
Why?
Congresses as Topic
1
2013
216
0.020
Why?
Administration, Oral
1
2014
787
0.020
Why?
Inflammation
1
2002
2750
0.020
Why?
Antigens, Human Platelet
1
2011
2
0.020
Why?
Japan
1
2011
98
0.020
Why?
Latin America
1
2011
87
0.020
Why?
Genetic Predisposition to Disease
1
2019
2274
0.020
Why?
Alanine-tRNA Ligase
1
2009
4
0.020
Why?
Threonine-tRNA Ligase
1
2009
4
0.020
Why?
Psychiatric Status Rating Scales
1
2011
533
0.020
Why?
Syndrome
1
2009
340
0.020
Why?
DNA Topoisomerases, Type I
1
2008
14
0.020
Why?
Animals
1
2010
35391
0.020
Why?
Cell Proliferation
1
2015
2373
0.020
Why?
Lymphocytes
1
2009
378
0.020
Why?
Pulmonary Wedge Pressure
1
2007
66
0.020
Why?
Body Mass Index
1
2015
2274
0.020
Why?
Risk Assessment
1
2015
3262
0.020
Why?
Muscle, Skeletal
1
2015
1613
0.020
Why?
Nuclear Proteins
1
2008
660
0.010
Why?
Child
1
2002
20884
0.010
Why?
Pneumonia
1
2008
617
0.010
Why?
Swigris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)